,date,tweet,past_tense,present_tense,future_tense,replies_count,retweets_count,likes_count,pos_score,neg_score,neutral_score,sentiment,Sentiment_Score,user
0,2018-04-05 21:13:03,"$VSAT -5% as Eutelsat ditches ViaSat-3. They sold ViaSat a dismal European retail business for $150m, promised a future broadband partnership, then walked away  ",1,1,0,0,3,7,0.013817193,0.91038156,0.075801216,Neg,-0.89656436,kerrisdalecap
1,2018-04-04 13:58:00,"$PTI is now hyping up another FDA designation — fast track for its proposed triple combination. But the bar for this designation is low, and it reflects preclinical data the market already knows about. Snooze. PTI-428 is still a dud.",1,1,0,1,5,5,0.046537142,0.09649236,0.8569705,Neu,-0.049955215,kerrisdalecap
2,2018-03-29 20:11:05," A little small for us, but we'll take a look",0,0,1,1,0,2,0.13764775,0.012186347,0.8501659,Neu,0.1254614,kerrisdalecap
3,2018-03-29 19:25:02,"Neat podcast by  editors  and  on our campaign on $PTI. Worthwhile listen for any longs and shorts on $PTI, and their podcast series is just a great concept altogether. Always valuable to listen to two folks debate the merits of an idea  ",0,1,0,2,2,7,0.064080216,0.016949106,0.9189707,Neu,0.04713111,kerrisdalecap
4,2018-03-27 15:28:01,$KODK breaks below $5. Crypto gambit stalling. Try coolers next?    What is the coolest product Kodak has licensed its logo to?,1,1,0,1,0,7,0.057374567,0.07664264,0.8659828,Neu,-0.019268073,kerrisdalecap
5,2018-03-22 14:12:02,Fun interview with  on shorting in today’s environment. She’s finally forgiven me for going long $HLF back in the day  ,1,1,0,0,1,8,0.4541705,0.03147757,0.51435196,Neu,0.42269292,kerrisdalecap
6,2018-03-21 13:24:05,"$PTI: Glad to see secondary canceled in response to our report. Investors are asking management to address our points – selectively disclosed data, missing biomarkers, disappearing trial etc. – before they hand over another $50m",1,1,0,1,2,22,0.21302661,0.015901664,0.77107173,Neu,0.19712494,kerrisdalecap
7,2018-03-20 13:31:01,"Argument here is similar to Bavarian Nordic, where we correctly predicted Phase 3 failure years in advance based in part on a bad Phase 2 placebo group and a questionable mechanism of action. With an ineffective drug, $PTI is worth cash per share at best ($2) (5/5)",1,1,0,0,2,6,0.060345203,0.57277143,0.3668834,Neg,-0.51242626,kerrisdalecap
8,2018-03-20 13:31:00,"What happened to $PTI's trial of PTI-428 with Kalydeco, which was supposed to read out this quarter? Why don't they talk about it anymore? Why don't they talk about the journal article that shows PTI-428 failing to increase protein levels or channel function? (4/5)",1,1,0,1,2,5,0.029192194,0.26991618,0.7008917,Neu,-0.24072398,kerrisdalecap
9,2018-03-20 13:30:04,"Meanwhile, $PTI data (or lack thereof) shows that the drug doesn't improve sweat chloride. Other endpoints supposedly measured haven't been reported -- why not? CFTR mRNA and protein data thus far are noisy and meaningless, despite company spin (3/5)",1,1,0,1,2,5,0.021397557,0.72947437,0.24912803,Neg,-0.70807683,kerrisdalecap
10,2018-03-20 13:30:02,"$PTI claims its ""amplifier"" drug for CF improves lung function, but patients on the drug barely improved on average; they only looked good in comparison with an anomalously bad placebo group. A normal placebo group would reveal that the drug is ineffective (2/5)",1,1,1,1,3,4,0.25991,0.6893156,0.05077435,Neg,-0.42940563,kerrisdalecap
11,2018-03-20 13:30:01,"We're short $PTI. Report available at   Stock has run up on unimportant breakthrough-therapy designation, but the underlying clinical data is terrible. The drug is a dud. Conf call 10:30am (866-834-3313), reference Kerrisdale call (1/5)",1,1,0,6,13,26,0.03393082,0.13236155,0.83370763,Neu,-0.09843072,kerrisdalecap
12,2018-03-19 20:17:03,"Tomorrow we're writing on a low quality biotech whose stock recently skyrocketed on minor news. Junky data, murky mechanism of action, negative results swept under the rug, weak results spun as successes. Just in time for a stock offering?",1,1,0,11,4,39,0.024378963,0.80268955,0.17293152,Neg,-0.7783106,kerrisdalecap
13,2018-03-13 18:36:03,Nice work  Weak foreign affiliates were rampant during the era of Chinese frauds; Big-4 self-monitoring is one of the best ways to limit fraud abroad from hitting US investors. Reminds us of BDO's fake bank website and 1 of our fave 8Ks    ,1,1,0,1,2,21,0.07001029,0.036803897,0.8931858,Neu,0.033206392,kerrisdalecap
14,2018-02-28 16:29:05," Thx -- we've continued to be short since the presentation. The stock has gone all over the place, but the company has been and continues to be fundamentally insolvent the whole time",1,1,0,0,0,0,0.013290851,0.9435701,0.043139152,Neg,-0.93027925,kerrisdalecap
15,2018-02-22 21:04:02,Happy to welcome the newest member of   ,0,0,0,4,3,74,0.7149142,0.00948073,0.27560508,Pos,0.7054335,kerrisdalecap
16,2018-02-07 17:07:00," It’s an honor, thank you",0,1,0,1,3,27,0.569071,0.014182598,0.4167464,Pos,0.55488837,kerrisdalecap
17,2018-02-07 14:30:05,"Meanwhile, $KODK financials are in free fall. Covenant breach and restructuring are inevitable. Negative FCF, $62m in ’17 EBITDA, $600m in debt, company says trends not improving. $KODK equity is worthless. (5/5)",0,1,0,0,5,41,0.007684876,0.9695126,0.022802426,Neg,-0.9618277,kerrisdalecap
18,2018-02-07 14:30:03,"The KODAKOne team has zero credibility. AppCoin head has checkered, stock promoter past & prior securities law violations. WENN Digital team unknown, unproven. And $KODK board members awarded shares to themselves day before announcement -- could be an SEC violation (4/5)",1,1,1,6,13,51,0.010429276,0.9025851,0.08698563,Neg,-0.8921558,kerrisdalecap
19,2018-02-07 14:29:05,"Cryptographically hashing an image into a blockchain doesn’t prove the provenance of intellectual property, a blockchain does not reduce the resources necessary for copyright enforcement, no photographer would rather be paid in KODAKCoins over real money. (3/5)",1,1,1,4,7,35,0.034813527,0.080113634,0.8850728,Neu,-0.045300107,kerrisdalecap
20,2018-02-07 14:29:04,KODAKOne and KODAKCoin are PR stunts. A cryptocurrency for image rights licensing makes no sense. Blockchain cannot fix the problem of IP ownership and does nothing for enforcement. (2/5),0,1,1,1,10,33,0.021328358,0.34065205,0.63801956,Neu,-0.3193237,kerrisdalecap
21,2018-02-07 14:29:02,"We're short $KODK. Report available at   KODK's crypto ventures are worthless and the company is hurtling towards bankruptcy. 100% downside, HODL to zero. Conf call 10:30am (888-567-1603, reference Kerrisdale call) (1/5)",0,1,0,31,84,286,0.0119133415,0.851467,0.1366196,Neg,-0.83955365,kerrisdalecap
22,2018-02-06 21:18:03,Crypto. We haven't come across a theme this big since the Chinese frauds. First report coming tomorrow – blockchain fever won't save this company from bankruptcy.,1,1,1,9,12,61,0.040256128,0.7378053,0.22193857,Neg,-0.69754916,kerrisdalecap
23,2018-02-05 17:11:00,$PRTA -20% as Chief Medical Officer quits. Stock cut in half since our report a few months ago. Market showing little confidence in NEOD001's prospects as we get closer to results,1,1,0,1,2,9,0.010306728,0.9711183,0.018575005,Neg,-0.96081156,kerrisdalecap
24,2018-01-29 21:56:03,"Another setback for $NAK, down -20% today. Opposition to the Pebble mine cuts across party lines. SaveBristolBay  ",0,0,0,2,0,2,0.014526407,0.9616054,0.02386815,Neg,-0.947079,kerrisdalecap
25,2018-01-26 17:43:03,"Neil, you’ll lose money on your bad investments regardless of whether we write on them. But hopefully our work helps the widows and orphans who invest in your Patient Capital Trust recognize just how poor your diligence is on the stocks you pick.  ",0,1,0,12,30,116,0.17550734,0.03311596,0.7913767,Neu,0.14239138,kerrisdalecap
26,2017-11-20 21:12:02,"$PRTA pushed back the timeline for Phase 3 VITAL trial by a year, Wedbush slashes PT from $75 to $55. Stock down -14%",1,1,0,2,2,5,0.008499485,0.9679974,0.023503153,Neg,-0.95949787,kerrisdalecap
27,2017-11-17 20:08:05,"The auto vertical ($LXFT’s 2nd largest now at 18% of revenue) grew 76% y-o-y on strength of autonomous driving. OEMs will continue to rely on high-end vendors like $LXFT. Company is a long term growth story worth $100+. Developers, developers, developers! (2/2)  ",1,1,1,0,0,9,0.92499393,0.009097231,0.0659089,Pos,0.9158967,kerrisdalecap
28,2017-11-17 20:07:02,"$LXFT reported strongs s, shares up 14%. Updated report at   Revenue growth of 38% excluding DB/UBS. Despite fear that DB/UBS would fall further, sales from DB/UBS increased sequentially 14% and 7%. Businesses outside of top 5 grew &gt;40% (1/2)",1,1,1,3,2,9,0.9459282,0.037362732,0.016709097,Pos,0.90856546,kerrisdalecap
29,2017-11-09 18:11:00,"$VSAT reported another weak quarter last night. Revenue fell -3% y/y, EBITDA -34%. Subs declined -14% y/y, -6% q/q to 589k. Mgmt said Dec qtr would return to sub growth, on ccall revised Dec to be neg again.   How low will subs ultimately go?",1,0,1,0,3,5,0.008363402,0.9601578,0.031478684,Neg,-0.9517944,kerrisdalecap
30,2017-11-08 18:11:05,"$PRTA shares slide during management's 11:50am Credit Suisse conference ""fireside"" chat, as mgmt decides to ignore our report. Stock -10%  ",0,1,0,2,4,10,0.008067116,0.96439624,0.027536634,Neg,-0.9563291,kerrisdalecap
31,2017-11-08 14:32:01,"PRX002 also showed no positive trend in Ph. 1b despite shotgun approach to endpoints, Ph. 2 is merely longer Ph. 1b & will be no different. We will publish separate report on PRX002. Reasons it does not work likely same as why amyloid-beta mAbs for Alzheimer’s failed $PRTA",1,1,1,0,0,1,0.09478289,0.03308314,0.8721339,Neu,0.061699748,kerrisdalecap
32,2017-11-08 14:31:04,"Antibody approach to amyloidosis has been tried and has consistently shown zero activity in the heart in radioimaging studies. Even w/o heart-specific issue, antibodies fail to work due to heterogeneity in amyloids, and epitope is blocked/destroyed/degraded $PRTA",1,1,0,2,0,2,0.014812329,0.86581963,0.11936809,Neg,-0.8510073,kerrisdalecap
33,2017-11-08 14:30:05,"$PRTA touts ~50% ""best response"" rate but this is product of high variance in biomarker being measured (NT-proBNP), not efficacy. Wk-to-wk variance in NT-proBNP is 35%, we expect ~50% of placebo patients to hit a 30% decline one time over 12 months too",1,1,0,2,0,3,0.05618748,0.91511667,0.02869594,Neg,-0.85892916,kerrisdalecap
34,2017-11-08 14:30:04,"Ph. 1/2 results for NEOD001 missing all elements of efficacy — no actual clinical response, no dose response, no improvement over time. Amyloid researchers believe it will fail; coinventors of NEOD001 predecessor & others told us “almost zero” prob of clinical success $PRTA",1,1,1,2,1,3,0.19031847,0.16885172,0.64082986,Neu,0.021466747,kerrisdalecap
35,2017-11-08 14:30:00,"We’re short $PRTA. Report available at   Main drug NEOD001 has no effect on patients and no chance of clinical success. Conf call 10:30am (888-567-1602, reference Kerrisdale call)",0,1,0,5,9,13,0.018598273,0.13593304,0.84546864,Neu,-0.11733477,kerrisdalecap
36,2017-11-07 21:26:04,"Tmrw, we write on a $1b+ biotech short owned by a famously bad bio investor, previously written on by another shortseller. Pipeline worth $0",1,1,0,11,16,56,0.06207705,0.02473487,0.9131881,Neu,0.03734218,kerrisdalecap
37,2017-11-03 13:37:03,$ADMS: Productive call/update last night. Interesting new tidbit - 40% of Gocovri patients experience ≥50% reduction in dyskinesia. High s!,0,1,0,1,0,5,0.24208653,0.38651726,0.37139624,Neg,-0.14443073,kerrisdalecap
38,2017-11-02 18:38:00,$ADMS: Replay from yesterday's call available at  ,0,0,0,0,1,6,0.025685534,0.0266993,0.9476152,Neu,-0.001013767,kerrisdalecap
39,2017-11-01 14:26:03,"$ADMS: Dial in for our 10:30am conference call : 888-567-1602, reference Kerrisdale Capital call",0,0,0,0,2,3,0.023357507,0.030035643,0.9466068,Neu,-0.006678136,kerrisdalecap
40,2017-11-01 13:03:02,$ADMS is also a tempting M&A target for other pharma co's. Cutting redundant SG&A & accelerating the sales ramp would deliver add'l upside.,0,1,1,0,1,3,0.7177464,0.21100466,0.07124891,Pos,0.5067417,kerrisdalecap
41,2017-11-01 13:03:00,"We value core $ADMS at $65/sh. But its pipeline is also undervalued. Assuming 50% prob of success, we see an add'l $37/sh, for &gt;$100 total.",1,1,0,3,2,8,0.88704216,0.028553907,0.084404,Pos,0.85848826,kerrisdalecap
42,2017-11-01 13:02:05,The skeptics are wrong: Gocovri really is better. Patients who switch from generic amantadine to Gocovri greatly improve. It's a good drug.,0,1,0,1,1,2,0.74482864,0.023331378,0.23183998,Pos,0.72149724,kerrisdalecap
43,2017-11-01 13:02:02,"But $ADMS is heavily shorted (33% of shares, 47% of float) and has a small mkt cap. Skeptics see it as a me-too drug, not a real advance.",1,1,0,1,0,3,0.06520787,0.047986288,0.8868059,Neu,0.017221581,kerrisdalecap
44,2017-11-01 13:01:04,"In the US alone, Gocovri's addressable market is $3.5 billion. Doesn't take much share to make this a billion-dollar/blockbuster drug.",0,1,0,2,1,2,0.11506052,0.009634772,0.8753047,Neu,0.10542575,kerrisdalecap
45,2017-11-01 13:01:01,"$ADMS's Gocovri is the only FDA-approved drug for a terrible side effect of Parkinson's treatment, dyskinesia ( ",0,1,0,1,1,3,0.23211594,0.026172055,0.74171203,Neu,0.20594388,kerrisdalecap
46,2017-11-01 13:00:03,We're long $ADMS and own 7% of its shares. Full report at   Conf call at 10:30. Company worth 4x+ where it's trading,0,1,0,3,12,22,0.071632944,0.010831796,0.91753525,Neu,0.06080115,kerrisdalecap
47,2017-10-31 20:14:03,We've bought 7% of a heavily shorted biotech that's worth 4x+ higher than current trading levels. Releasing report tomorrow.,1,1,0,30,13,67,0.3327554,0.010084738,0.6571599,Neu,0.32267064,kerrisdalecap
48,2017-10-13 05:01:05,   With $VSAT certainly the most superior,0,0,0,0,0,1,0.41561812,0.020710766,0.5636711,Neu,0.39490736,kerrisdalecap
49,2017-10-08 19:42:00,Swapping war stories with short activists    at this year's  conference  ,0,1,0,3,2,48,0.044103123,0.04613318,0.9097637,Neu,-0.002030056,kerrisdalecap
55,2017-09-07 16:41:05,Excited to speak alongside legends   & some A+ short activists   shortingforacause,1,1,0,0,4,5,0.090917364,0.014416083,0.8946665,Neu,0.07650128,kerrisdalecap
56,2017-08-29 15:06:01,$SAGE SRSE results should be out soon  ,0,0,1,1,0,1,0.10829463,0.034219585,0.8574857,Neu,0.07407504,kerrisdalecap
57,2017-08-28 15:18:04,"Last wk, $ALM.LN drops 25% after another Woodford-backed co collapses & $VSAT loses Alaska Airlines contract to $GOGO. Downward spirals",0,1,0,0,0,2,0.009940813,0.9720825,0.01797678,Neg,-0.9621417,kerrisdalecap
59,2017-08-09 13:00:01,"EBITDA -24%, costs up w/VSAT2 launch, ARPU flat Q/Q, comm networks neg EBITDA doubled from -$24m to -$50m y/y. Sat home internet doomed 3/3",1,1,0,0,0,3,0.9483251,0.03285847,0.018816516,Pos,0.9154666,kerrisdalecap
60,2017-08-09 12:59:03,"""Saw increased disconnect pressure due to both unlimited mobile LTE plans and the new use Jupiter 2"" -Direct quote from conf call 2/3",1,1,0,1,1,3,0.4152445,0.022829654,0.56192577,Neu,0.39241484,kerrisdalecap
62,2017-08-01 23:22:01,  the biotech media mafia,0,0,0,1,0,2,0.032886177,0.028113618,0.9390002,Neu,0.004772559,kerrisdalecap
63,2017-08-01 20:54:04," Carriers have no interest in satellite home internet. Rather, their wireless home internet offering renders sat internet obsolete",1,1,0,0,1,1,0.039680455,0.016068548,0.944251,Neu,0.023611907,kerrisdalecap
64,2017-08-01 14:27:01,"$VSAT: We've posted 3 updates to   on the satellites' true usable capacity, spectrum risks and co's poor forecasting",1,1,0,0,1,4,0.13745885,0.7318154,0.13072573,Neg,-0.59435654,kerrisdalecap
65,2017-07-26 14:21:00,"Citi's Jason Bazinet, author of last yr's ""prebuttal"" to our $DISH short, throws in towel, downgrades from buy to sell. Where's our apology?",0,1,0,3,3,21,0.021380305,0.8062075,0.17241223,Neg,-0.7848272,kerrisdalecap
67,2017-07-06 14:02:01,"  That's an elegant infographic on ""Talks that Stalled"". It's hard to get a deal done when mkt values your asset more highly than strategics",1,1,0,1,0,1,0.047487296,0.11015426,0.84235847,Neu,-0.06266697,kerrisdalecap
68,2017-06-28 15:16:02," Lots to say, here's a few: A) We just think theyre wrong here B) Too big now to exit C) Holding static past 5yrs, except for 4Q16 offering",0,1,0,0,0,0,0.032606535,0.18148,0.7859134,Neu,-0.14887348,kerrisdalecap
69,2017-06-28 14:34:05,$VSAT: New updates to   followup pieces on 1) aviation biz and 2) hidden costs of modem upgrades. New FAQs as well,0,0,0,1,2,2,0.1200116,0.010771074,0.86921734,Neu,0.109240524,kerrisdalecap
70,2017-06-28 00:02:01,"  Ok deal, we're in",0,1,0,0,0,1,0.6689885,0.015568175,0.3154433,Pos,0.6534203,kerrisdalecap
71,2017-06-27 23:54:05,  We'll subscribe if you cover my next biotech short. Deal?,0,1,1,1,0,2,0.07813881,0.015384067,0.9064771,Neu,0.06275475,kerrisdalecap
72,2017-06-27 14:28:02,"$VSAT: With Mark attending, we expect majority of top 10 holders (excluding index funds) to join Thurs event. Should be a spirited debate",0,1,1,0,2,3,0.15983081,0.012762504,0.8274067,Neu,0.1470683,kerrisdalecap
73,2017-06-26 23:27:02, For an event like this - which will likely attract major holders now given the presence of the CEO - debate will be private & confidential,1,0,1,0,0,1,0.033356883,0.023134217,0.94350886,Neu,0.010222666,kerrisdalecap
74,2017-06-26 14:46:04," Arguments that disprove our thesis would make us rethink the short. With years of mgmt call, event transcripts, we think we know his views",0,1,1,1,0,5,0.06070489,0.059065938,0.8802292,Neu,0.0016389526,kerrisdalecap
75,2017-06-26 14:00:02,"$VSAT CEO coming to Thursday's investor dinner to debate us. Kudos to Mark Dankberg, he'll be first in short activism history to do so",0,1,1,7,11,42,0.062202144,0.016784908,0.92101294,Neu,0.045417234,kerrisdalecap
77,2017-06-23 14:16:02,"We participated in a great dinner on $VSAT with institutional investors last night. Covered lots of ground, looking fwd to the one in Boston",1,1,0,0,0,1,0.6271032,0.012983045,0.35991374,Pos,0.6141202,kerrisdalecap
78,2017-06-20 14:16:05,$VSAT: We've launched   where we'll keep an ongoing FAQ and post more detailed follow-ups on specific topics,1,1,1,1,1,4,0.043711063,0.0147241475,0.9415648,Neu,0.028986916,kerrisdalecap
79,2017-06-16 16:11:04,"$VSAT fun fact of the day: we have 14x more twitter followers than  US satellite home internet is tiny, temporary tech w finite life",0,1,0,0,0,2,0.026567755,0.3347977,0.6386345,Neu,-0.30822995,kerrisdalecap
80,2017-06-15 14:50:02,$VSAT: Replay of Tuesday's conference call:  ,0,0,0,0,0,4,0.018338207,0.058219805,0.923442,Neu,-0.0398816,kerrisdalecap
81,2017-06-14 23:57:02,"   It's hard to debate in 140 characters. I'm at 212-792-9148, sadrangi Talking to lots of longs rn, so call/email me",0,1,0,1,0,0,0.023664862,0.08265995,0.89367515,Neu,-0.05899509,kerrisdalecap
82,2017-06-14 23:50:01,   Explain to me how hiding from the opposing view helps you in your investment process,0,1,0,0,0,0,0.08962352,0.015054359,0.89532214,Neu,0.07456916,kerrisdalecap
83,2017-06-14 23:49:01,   I sense sarcasm. Why don't we talk through the arguments for an hr. It'll be clear pretty quick who's done the work. What are you afraid of?,1,1,1,2,0,0,0.038613077,0.12683628,0.8345507,Neu,-0.088223204,kerrisdalecap
84,2017-06-14 22:37:04,   Why are you afraid to talk to us about $VSAT  Which of the Boston funds that hold it do you work at? Let's chat it out,0,1,0,1,0,0,0.027141303,0.042926244,0.9299324,Neu,-0.015784942,kerrisdalecap
85,2017-06-14 21:05:00,"  And our $DISH target px was $20, so you can make that red band for DISH just as long as the green one :)",1,0,1,2,0,0,0.048216168,0.018338706,0.9334451,Neu,0.029877461,kerrisdalecap
86,2017-06-14 14:35:03,$VSAT: 5x volume traded yesterday -- that's the start of a healthy debate. Below we detail our 10 upcoming followups. Lots to discuss.  ,1,1,0,0,3,1,0.058443118,0.016804326,0.92475253,Neu,0.04163879,kerrisdalecap
87,2017-06-13 15:13:04,"$VSAT: Conference call to discuss report at 10:30am.  Dial-in: 888-567-1602, 862-255-5346 / Reference Kerrisdale call",0,0,0,0,1,6,0.01839573,0.048278123,0.9333262,Neu,-0.029882394,kerrisdalecap
88,2017-06-13 14:35:01,"Sat internet imposes data caps on customers. As streaming booms, all subs will migrate to providers with no caps. $VSAT's $5B EV will vanish",0,1,1,1,0,1,0.041089974,0.032169323,0.92674077,Neu,0.008920651,kerrisdalecap
89,2017-06-13 14:31:05,"4g LTE home broadband from $VZ, $T, not to mention DSL, is faster and cheaper than satellite internet, increasingly available everywhere",0,1,0,3,0,1,0.2831653,0.009534224,0.7073004,Neu,0.2736311,kerrisdalecap
90,2017-06-13 14:30:04,"$VSAT is free cash flow negative every yr from 2009 to 2022+, constantly re-investing in a biz that will go extinct by 2023",0,1,1,1,0,3,0.20198716,0.14357328,0.65443957,Neu,0.058413878,kerrisdalecap
91,2017-06-13 14:30:01,"We're short $VSAT, report at   Thesis is simple: satellite home internet has no future in the US. 50%+ downside",0,1,0,5,10,27,0.04888991,0.2249559,0.7261542,Neu,-0.176066,kerrisdalecap
92,2017-06-12 21:24:05,"For our multibillion dollar telecom short this yr, tomorrow we revisit the sector that started us off. This one's main biz is going to zero",1,1,0,4,6,18,0.12603101,0.09758896,0.77638006,Neu,0.028442055,kerrisdalecap
93,2017-06-01 15:49:01," We expect SBC to be similar % of sales next few yrs. A negative, but we also look at growth, EV/Rev, FCF, qualitative factors (ie TAM, moat)",0,1,0,1,0,0,0.15824583,0.45292068,0.38883352,Neg,-0.29467484,kerrisdalecap
94,2017-05-23 20:36:04, Yes and I think there were probably a lot of buyers waiting in the wings at that 61 level today,1,1,0,0,0,1,0.17162141,0.027003884,0.80137473,Neu,0.14461753,kerrisdalecap
97,2017-05-09 14:32:01,"We believe $PLSE has &gt;90% downside as the hype fizzles and commercialization efforts falter, as with many other similar products. 6/6",0,1,0,1,1,7,0.011548209,0.96831125,0.020140471,Neg,-0.956763,kerrisdalecap
98,2017-05-09 14:31:04,New $PLSE-funded data (not disclosed by mgmt) shows 10-20% of human cancer cells survive even the most intense nano-pulse regimen. Sad! 5/6,1,1,0,1,1,0,0.13062029,0.014457255,0.8549225,Neu,0.11616303,kerrisdalecap
99,2017-05-09 14:31:01,"$PLSE pitch closely resembles that of NanoKnife, a product made by $ANGO that the mkt values at only ~$30m. Yet $PLSE trades 10x higher 4/6",1,1,0,1,1,0,0.923092,0.026872797,0.050035212,Pos,0.8962192,kerrisdalecap
100,2017-05-09 14:30:05,"$PLSE touts its first-in-human trial as a win, but look at the results. Efficacy far worse than surgery. These are the ""after"" pictures! 3/6  ",0,1,0,1,1,0,0.061134193,0.6089091,0.32995674,Neg,-0.54777485,kerrisdalecap
101,2017-05-09 14:30:01,"$PLSE claims its ""nano-pulse stimulation"" tech has unique cancer-fighting powers. In fact, many other treatments have same properties 2/6",0,1,0,1,1,1,0.17096882,0.009462259,0.8195689,Neu,0.16150656,kerrisdalecap
102,2017-05-09 14:30:00,We're short $PLSE. Full report at   This $400m med device co is up 6x since 2016 IPO yet has achieved very little 1/6,1,1,0,9,10,21,0.9269627,0.0233973,0.049640067,Pos,0.90356535,kerrisdalecap
103,2017-05-09 14:00:03,"Conf call today 10:30am: 888-567-1602, reference Kerrisdale. We'll also experiment with insta-live at 9:45am:  on instagram",0,0,1,0,1,1,0.037310336,0.014032595,0.94865704,Neu,0.02327774,kerrisdalecap
104,2017-05-08 21:30:01,"We'll publish on a new short tomorrow. Entranced by a billionaire investor, investors haven't done their homework on this one.",1,1,1,10,19,59,0.0790412,0.11824542,0.80271333,Neu,-0.039204225,kerrisdalecap
105,2017-04-13 20:35:01,"$DISH: We'll state the obvious. DISH bought so much in incentive auction and $VZ, $T so little because... there's no actual rational answer",1,1,1,5,7,10,0.034633394,0.09461427,0.8707524,Neu,-0.059980873,kerrisdalecap
106,2017-04-03 16:02:04,"$ALM.LN -9% amid a host of recent bad news (CEO out, Jefferies d/g to sell). Market catching up w/our 2015 report ( ",0,1,0,1,0,2,0.101021595,0.8450974,0.053880915,Neg,-0.74407583,kerrisdalecap
107,2017-03-03 17:35:05,Great article in this week's  discussing our work on $NAK and Pebble's futile future  ,0,1,0,1,4,15,0.22049716,0.010087373,0.7694155,Neu,0.21040979,kerrisdalecap
108,2017-02-24 15:02:02,Which is the bigger stock promote?,0,1,0,5,1,5,0.02980776,0.057405602,0.91278666,Neu,-0.027597843,kerrisdalecap
109,2017-02-17 20:17:04,$NAK's response effectively admits that Pebble personnel DID conclude costs would be uneconomically high. See also:  ,0,1,1,3,5,4,0.06690294,0.5430703,0.3900268,Neg,-0.47616738,kerrisdalecap
110,2017-02-16 19:15:03,$NAK: We have to share this wonderful email we got from a local fisherman. It's time to book that summer camping trip to Alaska!  ,1,1,0,4,5,25,0.31156203,0.015615559,0.6728224,Neu,0.29594648,kerrisdalecap
111,2017-02-15 19:09:04,$NAK: Received outpouring of support from local Alaskans who oppose neg impacts of Pebble mine. Making a personal donation   ,1,1,0,2,1,6,0.49776962,0.011735231,0.4904951,Pos,0.4860344,kerrisdalecap
112,2017-02-14 14:59:00,$NAK: We're hosting a conference call at 10:30am ET to discuss thesis. Call (888) 567-1602 and reference Kerrisdale call,0,1,0,2,2,8,0.033928566,0.016554452,0.94951695,Neu,0.017374113,kerrisdalecap
113,2017-02-14 14:34:04,$NAK is a heavily promoted stock; mgmt loves to tell stories. They hid damning analysis of their only real asset. What else are they hiding?,0,1,0,6,1,8,0.025095727,0.33934292,0.63556135,Neu,-0.3142472,kerrisdalecap
114,2017-02-14 14:34:02,"Even if Trump EPA drops Obama veto of $NAK project, next Dem president will reinstate it. No partner will invest with that kind of overhang",0,1,1,3,0,9,0.05255056,0.02606434,0.9213851,Neu,0.026486222,kerrisdalecap
115,2017-02-14 14:34:00,"On the regulatory front, $NAK isn't out of the woods yet. It's deeply unpopular in Alaska. State legislature is ready & willing to block it",0,1,0,0,0,3,0.035165537,0.4928396,0.47199488,Neg,-0.45767406,kerrisdalecap
117,2017-02-14 14:32:05,"$NAK deposit may be big, but it's low-grade. Requires yuge amounts of costly infrastructure. Awful ROI, not EPA, scared away past partners",1,1,1,3,1,6,0.05728384,0.3363872,0.60632896,Neu,-0.27910334,kerrisdalecap
119,2017-02-14 14:31:03,"We're short $NAK, report:   Trump may rescind EPA veto but $NAK still worth $0 b/c its mine isn't commercially viable  ",1,1,1,29,12,28,0.041019436,0.13357428,0.82540625,Neu,-0.09255484,kerrisdalecap
120,2017-02-14 13:08:01,"We'll try something new today -- we'll Instagram Live 1st hr of trading at 9:30am, answering q's. Add  on Insta, tune in 9:30",0,1,1,3,3,6,0.0645554,0.012094616,0.92335,Neu,0.052460782,kerrisdalecap
121,2017-02-13 21:19:01,We will publish a report on a short tomorrow. Bulls believe Trump will make this company great again but that's FAKE NEWS. Very dishonest!,0,1,1,10,19,63,0.021191863,0.79746145,0.1813467,Neg,-0.7762696,kerrisdalecap
122,2017-02-01 16:37:04,$STRP: We examine mmWave 5G & its steep challenges. Costs too much to deploy for services customers won’t pay for:  ,1,1,0,4,4,4,0.07766488,0.41322085,0.5091142,Neu,-0.33555597,kerrisdalecap
123,2017-01-26 16:00:03,"$DISH -7%,  says VZ wants to buy cable co. No $ left for DISH. Carriers waiting to 2020 for FCC to take AWS4 from DISH ",1,1,0,0,2,6,0.044286832,0.02018658,0.9355266,Neu,0.024100251,kerrisdalecap
124,2017-01-25 16:49:05,Congrats to our esteemed follower  for being named Chairman of the  Making spectrum policy great again,1,1,0,0,0,3,0.7433223,0.0100381235,0.24663961,Pos,0.7332842,kerrisdalecap
125,2017-01-24 17:24:04,"$STRP: Files shelf reg, preps for equity offering, stock -6%. It makes sense: Co. can make far more $$ selling stock than selling spectrum",0,1,1,5,3,12,0.06593259,0.022239123,0.91182834,Neu,0.043693464,kerrisdalecap
127,2017-01-19 21:13:05,"Since everyone liked our morning poll so much, here's the next one. Will $STRP sell itself for $500m+?",1,1,1,7,1,4,0.05046211,0.02236368,0.9271742,Neu,0.028098432,kerrisdalecap
128,2017-01-19 14:31:00,"If $STRP doesn’t sell in 12 months, the FCC has reserved the right to re-open the investigation and potentially take licenses away 5/5",1,1,0,0,1,7,0.019323293,0.63405937,0.3466174,Neg,-0.6147361,kerrisdalecap
129,2017-01-19 14:30:03,"Using $VZ/XO comp and adding FCC penalties, we see 70%+ downside from here 4/5",0,1,0,1,1,3,0.133756,0.83334464,0.032899357,Neg,-0.69958866,kerrisdalecap
130,2017-01-19 14:30:00,High-freq bands still unlikely to be very valuable. Lot of supply; commercial viability many yrs away; will be very costly to deploy 3/5,0,0,1,1,0,2,0.058300134,0.76580936,0.17589055,Neg,-0.7075092,kerrisdalecap
131,2017-01-19 14:29:03,$STRP trades for $500mm. $VZ is set to buy XO's similar spectrum portfolio for $200mm. XO spectrum is better 2/5,1,1,0,2,2,5,0.6610164,0.08148055,0.2575031,Pos,0.57953584,kerrisdalecap
132,2017-01-19 14:29:00,We’re short $STRP. Report is at   Conference call today at 10:30: 888-567-1602 (US/Can) or 862-255-5346 (int'l) 1/5,0,1,0,15,14,20,0.017210774,0.09438726,0.888402,Neu,-0.07717649,kerrisdalecap
133,2017-01-19 13:15:02,Which 'oldie but goodie' stock are we going to publish on today?,0,1,0,5,2,1,0.027500793,0.03727022,0.93522894,Neu,-0.0097694285,kerrisdalecap
134,2017-01-18 21:18:05,We're issuing a new report tomorrow on a wildly overvalued short. It's an oldie but a goodie,1,1,0,14,5,30,0.31710246,0.0715427,0.61135477,Neu,0.24555975,kerrisdalecap
